Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DexCom Inc (NASDAQ:DXCM)

81.89
Delayed Data
As of Feb 17
 +0.50 / +0.61%
Today’s Change
56.52
Today|||52-Week Range
96.38
+37.17%
Year-to-Date
DexCom Is a Great Healthcare Stock to Buy Now
Feb 15 / TheStreet.com - Paid Partner Content
3 of the Highest-Growth Stocks in the Market Today
Feb 06 / MotleyFool.com - Paid Partner Content
John Paulson Buys Time Warner, Harman International Industries, B/E Aerospace, Sells ...
Feb 14 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close81.39
Today’s open81.06
Day’s range80.58 - 82.66
Volume632,647
Average volume (3 months)1,334,667
Market cap$6.9B
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-140.00%
Earnings growth (this year)-201.79%
Earnings growth (next 5 years)+32.50%
Revenue growth (last year)+55.09%
P/E ratioNM
Price/Sales16.26
Price/Book30.25

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...+1.07+1.30%
TFXTeleflex Inc+1.86+1.04%
ABMDAbiomed Inc+2.32+2.03%
MASIMasimo Corp+2.36+2.89%
Data as of 4:14pm ET, 02/17/2017

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$402.0M
Annual profit (last year)-$57.6M
Net profit margin-14.33%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Kevin Ronald Sayer
Senior Vice President-
Operations
Jeffrey C. Moy
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs